首页> 外文期刊>Molecular pharmaceutics >Novel Thermal Imaging Method for Rapid Screening of Drug-Polymer Miscibility for Solid Dispersion Based Formulation Development
【24h】

Novel Thermal Imaging Method for Rapid Screening of Drug-Polymer Miscibility for Solid Dispersion Based Formulation Development

机译:用于快速筛选药物 - 聚合物混溶性的新型热成像方法,其基于固体分散体的配方发育

获取原文
获取原文并翻译 | 示例
           

摘要

This study aimed to develop a rapid, simple, and inexpensive screening method for selecting the best polymeric candidates possessing high active pharmaceutical ingredient (API) miscibility during the early stages of formulation development of solid dispersion based pharmaceutical products. A new thermal imaging based method, thermal analysis by structural characterization (TASC), was used as a thermoptometric tool in conjunction with data analysis software to detect the melting point depression and postmelting dissolution of felodipine particles screened over thin spin-coated films of ten polymers commonly used in the pharmaceutical field. On the polymeric substrates the drug showed different degrees of melting point reduction, reflecting their different levels of polymer drug miscibility. Using TASC to detect melting point depression is significantly (20-40 times) faster than the conventional DSC method without loss of the sensitivity of detection. The quantity of the material required for the screening is less than 1/1000th of the material used in conventional DSC tests, which significantly reduce the material wastage. Isothermal TASC tests and IR imaging confirmed the occurrence of thermal dissolution of the drug in the polymer for more miscible pairs. The real-time stability tests validate the accuracy of the polymer drug miscibility screening results. These results demonstrate TASC as a promising screening tool for rapidly selecting the polymeric excipients for pharmaceutical formulations development.
机译:本研究旨在开发一种快速,简单,廉价的筛选方法,用于选择具有高活性药物成分(API)的最佳聚合物候选物,所述高活性药物成分(API)混溶性在固体分散体基药品的制剂的早期阶段。基于新的热成像方法,通过结构表征(Tasc)的热分析,与数据分析软件一起用作热量工具,以检测熔点抑制和筛选的十型聚合物的薄旋涂的薄膜粒子的熔点抑制和脱胶溶解常用于药物领域。在聚合物基质上,药物显示出不同程度的熔点减少,反映了它们不同水平的聚合物药物混溶性。使用Tasc以检测熔点抑制显着(20-40次)比传统的DSC方法快,而不会损失检测灵敏度。筛选所需的材料的量小于传统DSC测试中使用的材料的1/1000,这显着降低了材料浪费。等温Tasc试验和IR成像证实了药物在聚合物中的热溶解的发生以进行更加混溶的对。实时稳定性试验验证了聚合物药物混溶性筛选结果的准确性。这些结果表明Tasc作为迅速选择药物制剂发育的聚合物赋形剂的有前途的筛选工具。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号